Over-expression of the p110β but not p110α isoform of PI 3-kinase inhibits motility in breast cancer cells

Shu Chin Yip, Mirvat El-Sibai, Karen M. Hill, Haiyan Wu, Zheng Fu, John S. Condeelis, Jonathan M. Backer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Phosphoinositide 3-kinase (PI 3-kinase) activity is required for growth factor-induced cytoskeletal regulation and cell migration. We previously found that in MTLn3 rat adenocarcinoma cells, EGF-stimulated induction of actin barbed ends and lamellipod extension specifically requires the p85/p110α isoform of PI 3-kinase. To further characterize signaling by distinct PI 3-kinase isoforms, we have developed MTLn3 cells that transiently or stably overexpress either p110α or p110β. Transient overexpression of p110β inhibited EGF-stimulated lamellipod extension, whereas p110α-transfected cells showed normal EGF-stimulated lamellipod extension. Similar results were obtained by overexpression of kinase-dead p110β, suggesting that effects on cytoskeletal signaling were due to competition with p85/p110α complexes. Stable overexpression of p110α appeared to be toxic, based on the difficulty in obtaining stable overexpressing clones. In contrast, cells expressing a 2-fold increase in p110β were readily obtainable. Interestingly, cells stably expressing p110 β showed a marked inhibition of EGF-stimulated lamellipod extension. Using computer-assisted analysis of time-lapse images, we found that overexpression of p110β caused a nearly complete inhibition of motility. Cells overexpressing p110 β showed normal activation of Akt and Erk, suggesting that overall PI 3-kinase signaling was intact. A chimeric p110 molecule containing the p85-binding and Ras-binding domains of p110α and the C2, helical, and kinase domains of p110β, was catalytically active yet also inhibited EGF-stimulated lamellipod extension. These data highlight the differential signaling by distinct p110 isoforms. Identification of effectors that are differently regulated by p110α versus p110β will be important for understanding cell migration and its role in metastasis.

Original languageEnglish (US)
Pages (from-to)180-188
Number of pages9
JournalCell Motility and the Cytoskeleton
Volume59
Issue number3
DOIs
StatePublished - Nov 2004

Fingerprint

1-Phosphatidylinositol 4-Kinase
Protein Isoforms
Epidermal Growth Factor
Breast Neoplasms
Cell Movement
Phosphotransferases
Poisons
Actins
Intercellular Signaling Peptides and Proteins
Adenocarcinoma
Clone Cells
Neoplasm Metastasis

Keywords

  • Actin
  • Adenocarcinoma
  • Breast cancer
  • Motility
  • PI 3-kinase

ASJC Scopus subject areas

  • Cell Biology

Cite this

Over-expression of the p110β but not p110α isoform of PI 3-kinase inhibits motility in breast cancer cells. / Yip, Shu Chin; El-Sibai, Mirvat; Hill, Karen M.; Wu, Haiyan; Fu, Zheng; Condeelis, John S.; Backer, Jonathan M.

In: Cell Motility and the Cytoskeleton, Vol. 59, No. 3, 11.2004, p. 180-188.

Research output: Contribution to journalArticle

@article{935c7427df6e4f3b9f6390d8e57324c4,
title = "Over-expression of the p110β but not p110α isoform of PI 3-kinase inhibits motility in breast cancer cells",
abstract = "Phosphoinositide 3-kinase (PI 3-kinase) activity is required for growth factor-induced cytoskeletal regulation and cell migration. We previously found that in MTLn3 rat adenocarcinoma cells, EGF-stimulated induction of actin barbed ends and lamellipod extension specifically requires the p85/p110α isoform of PI 3-kinase. To further characterize signaling by distinct PI 3-kinase isoforms, we have developed MTLn3 cells that transiently or stably overexpress either p110α or p110β. Transient overexpression of p110β inhibited EGF-stimulated lamellipod extension, whereas p110α-transfected cells showed normal EGF-stimulated lamellipod extension. Similar results were obtained by overexpression of kinase-dead p110β, suggesting that effects on cytoskeletal signaling were due to competition with p85/p110α complexes. Stable overexpression of p110α appeared to be toxic, based on the difficulty in obtaining stable overexpressing clones. In contrast, cells expressing a 2-fold increase in p110β were readily obtainable. Interestingly, cells stably expressing p110 β showed a marked inhibition of EGF-stimulated lamellipod extension. Using computer-assisted analysis of time-lapse images, we found that overexpression of p110β caused a nearly complete inhibition of motility. Cells overexpressing p110 β showed normal activation of Akt and Erk, suggesting that overall PI 3-kinase signaling was intact. A chimeric p110 molecule containing the p85-binding and Ras-binding domains of p110α and the C2, helical, and kinase domains of p110β, was catalytically active yet also inhibited EGF-stimulated lamellipod extension. These data highlight the differential signaling by distinct p110 isoforms. Identification of effectors that are differently regulated by p110α versus p110β will be important for understanding cell migration and its role in metastasis.",
keywords = "Actin, Adenocarcinoma, Breast cancer, Motility, PI 3-kinase",
author = "Yip, {Shu Chin} and Mirvat El-Sibai and Hill, {Karen M.} and Haiyan Wu and Zheng Fu and Condeelis, {John S.} and Backer, {Jonathan M.}",
year = "2004",
month = "11",
doi = "10.1002/cm.20032",
language = "English (US)",
volume = "59",
pages = "180--188",
journal = "Cytoskeleton",
issn = "1949-3584",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Over-expression of the p110β but not p110α isoform of PI 3-kinase inhibits motility in breast cancer cells

AU - Yip, Shu Chin

AU - El-Sibai, Mirvat

AU - Hill, Karen M.

AU - Wu, Haiyan

AU - Fu, Zheng

AU - Condeelis, John S.

AU - Backer, Jonathan M.

PY - 2004/11

Y1 - 2004/11

N2 - Phosphoinositide 3-kinase (PI 3-kinase) activity is required for growth factor-induced cytoskeletal regulation and cell migration. We previously found that in MTLn3 rat adenocarcinoma cells, EGF-stimulated induction of actin barbed ends and lamellipod extension specifically requires the p85/p110α isoform of PI 3-kinase. To further characterize signaling by distinct PI 3-kinase isoforms, we have developed MTLn3 cells that transiently or stably overexpress either p110α or p110β. Transient overexpression of p110β inhibited EGF-stimulated lamellipod extension, whereas p110α-transfected cells showed normal EGF-stimulated lamellipod extension. Similar results were obtained by overexpression of kinase-dead p110β, suggesting that effects on cytoskeletal signaling were due to competition with p85/p110α complexes. Stable overexpression of p110α appeared to be toxic, based on the difficulty in obtaining stable overexpressing clones. In contrast, cells expressing a 2-fold increase in p110β were readily obtainable. Interestingly, cells stably expressing p110 β showed a marked inhibition of EGF-stimulated lamellipod extension. Using computer-assisted analysis of time-lapse images, we found that overexpression of p110β caused a nearly complete inhibition of motility. Cells overexpressing p110 β showed normal activation of Akt and Erk, suggesting that overall PI 3-kinase signaling was intact. A chimeric p110 molecule containing the p85-binding and Ras-binding domains of p110α and the C2, helical, and kinase domains of p110β, was catalytically active yet also inhibited EGF-stimulated lamellipod extension. These data highlight the differential signaling by distinct p110 isoforms. Identification of effectors that are differently regulated by p110α versus p110β will be important for understanding cell migration and its role in metastasis.

AB - Phosphoinositide 3-kinase (PI 3-kinase) activity is required for growth factor-induced cytoskeletal regulation and cell migration. We previously found that in MTLn3 rat adenocarcinoma cells, EGF-stimulated induction of actin barbed ends and lamellipod extension specifically requires the p85/p110α isoform of PI 3-kinase. To further characterize signaling by distinct PI 3-kinase isoforms, we have developed MTLn3 cells that transiently or stably overexpress either p110α or p110β. Transient overexpression of p110β inhibited EGF-stimulated lamellipod extension, whereas p110α-transfected cells showed normal EGF-stimulated lamellipod extension. Similar results were obtained by overexpression of kinase-dead p110β, suggesting that effects on cytoskeletal signaling were due to competition with p85/p110α complexes. Stable overexpression of p110α appeared to be toxic, based on the difficulty in obtaining stable overexpressing clones. In contrast, cells expressing a 2-fold increase in p110β were readily obtainable. Interestingly, cells stably expressing p110 β showed a marked inhibition of EGF-stimulated lamellipod extension. Using computer-assisted analysis of time-lapse images, we found that overexpression of p110β caused a nearly complete inhibition of motility. Cells overexpressing p110 β showed normal activation of Akt and Erk, suggesting that overall PI 3-kinase signaling was intact. A chimeric p110 molecule containing the p85-binding and Ras-binding domains of p110α and the C2, helical, and kinase domains of p110β, was catalytically active yet also inhibited EGF-stimulated lamellipod extension. These data highlight the differential signaling by distinct p110 isoforms. Identification of effectors that are differently regulated by p110α versus p110β will be important for understanding cell migration and its role in metastasis.

KW - Actin

KW - Adenocarcinoma

KW - Breast cancer

KW - Motility

KW - PI 3-kinase

UR - http://www.scopus.com/inward/record.url?scp=7244221431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7244221431&partnerID=8YFLogxK

U2 - 10.1002/cm.20032

DO - 10.1002/cm.20032

M3 - Article

VL - 59

SP - 180

EP - 188

JO - Cytoskeleton

JF - Cytoskeleton

SN - 1949-3584

IS - 3

ER -